Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT
                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 11, 2005

                           Orthofix International N.V.
             (Exact name of Registrant as specified in its charter)

    Netherlands Antilles                0-19961                    N/A
(State or other jurisdiction    Commission File Number      (I.R.S. Employer
     of incorporation)                                    Identification Number)


                             7 Abraham de Veerstraat
                            Netherlands Antilles                   N/A
               (Address of principal executive offices)         (Zip Code)

     Registrant's telephone number, including area code: 011-59-99-465-8525


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

Item 2.02.      Results of Operations and Financial Condition

         On April 11, 2005, Orthofix International N.V. issued a press release
announcing, among other things, that first quarter sales exceeded its guidance
range for the first quarter ended March 31, 2005 and that the company reached an
agreement to conclude its 'Bone Source' licensing agreement with Stryker. A copy
of the press release is attached hereto as Exhibit 99.1 and is incorporated by 
reference herein.

Item 9.01.      Financial Statements and Exhibits

       (c)    Exhibits

       99.1   Press release of Orthofix International N.V. dated April 11, 2005.


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                ORTHOFIX INTERNATIONAL N.V.

                                                By: /s/ Thomas Hein
                                                Name:  Thomas Hein
                                                Title: Chief Financial Officer

Date:    April 12, 2005